| Subscribe Now |
![]() |
|
| Weather |
Bloomington-Normal, Illinois
|
| Home |
| NewsFriday, October 19, 2007 9:54 PM CDT |
Cold meds decision sad reminder for B-N family
B-N infant died after accidental overdose in 2001
BLOOMINGTON -- The Mehlberg-Alvarez family’s nightmare has returned. On Oct. 8, 2001, Devon J. Mehlberg-Alvarez, a 4-month-old Bloomington boy, died from a toxic level of dextromethoraphan, a cough suppressant in some over-the-counter cold medicines. Within the past week, drug manufacturers have ended sales of over-the-counter oral cough and cold medicines aimed at children age 2 and younger. The U.S. Food and Drug Administration is considering banning decongestants for children younger than 2 and antihistamines for children younger than 6. The developments result from health officials reporting deaths linked to unintentional overdoses of cough and cold medicine in children age 2 and younger. “I was infuriated,” Devon’s maternal grandmother, Deborah Mehlberg, said Thursday about the recent developments. “If we knew then what we know now, Devon would be alive.” Mehlberg spoke with the Pantagraph along with Ralph Davis, a Peoria attorney retained by the Mehlberg-Alvarez family, in the Bloomington home of Mehlberg’s daughter and Devon’s mother, Dimitria Mehlberg-Alvarez. Mehlberg-Alvarez declined comment. The family now knows that dextromethoraphan, a cough suppressant that slows breathing, has no therapeutic value but sedates infants so they and their parents can get rest, Davis argued. If the family had known that fact six years ago, Mehlberg-Alvarez would not have given the medicine to her son, Davis said. McLean County Coroner Beth C. Kimmerling said Thursday that her records indicate Mehlberg-Alvarez took Devon to a pediatrician on Oct. 4, 2001, because Devon had a cough. Devon’s medical records indicate the pediatrician recommended 0.4 cc of Pediacare infant drops, Kimmerling said. However, Mehlberg said Thursday that the pediatrician verbally told her daughter to give Devon a dropper full of Pediacare — 0.8 cc. Mehlberg-Alvarez told Kimmerling she bought Walgreen’s Pediatric Drops Cough & Cold and gave Devon a full dropper or 0.8 cc about three times a day for the next three days. Devon died on Oct. 8. “It was a nightmare,” Mehlberg said. “It was the hardest thing we’ve ever dealt with. I don’t want another family to have to go through what we went through. I will never be the same.” While Kimmerling said Mehlberg-Alvarez committed a dosing error and, according to Devon’s medical record, didn’t follow the doctor’s written recommendation, a written opinion by a toxicologist released at Devon’s inquest indicated the amount of medicine he received may have been proper if Devon had metabolized it. Mehlberg said the family is not blaming the pediatrician. Davis said blood tests after Devon’s death revealed the acetaminophen level in Devon’s blood was at therapeutic levels but the dextromethoraphan amount was at a fatal level. Because Devon was metabolizing one ingredient and not another, that would indicate that there was a problem with the ingredient — not that there was a unique problem with Devon or that his mother had overmedicated him, Davis said. Mehlberg recently became aware of other infant deaths among children who had used infant cough and cold medicine. Davis said he and the family are in the process of investigating. Dimitria Mehlberg-Alvarez and her husband, Melecio Alvarez, have four children: Donovan, 10; Alejandro, 9; Lilyana, 4½; and Isadora, 2½ months. Kimmerling said Devon’s death was the first and only case of its kind in McLean County. Mehlberg suggested that parents have their children undergo a blood test to determine whether they can metabolize dextromethoraphan. “I’d like to see this (over-the-counter) product removed completely for any age,” she said. |
|
||||||||
|
![]() ![]() |
|
Top of Page | Home | News | Sports | Free Time | Life | Money | Nation/World | Opinion | Blogs/Columns | Archives | Site Map | RSS
Copyright © 2009, Pantagraph Publishing Co. and Lee Enterprises. All rights reserved. | Terms of Use | Privacy Policy
|